Literature DB >> 403100

Investigation of insulin sensitivity in treated subjects with ketosis-prone diabetes mellitus.

H N Ginsberg.   

Abstract

Two similar intravenous infucion techniques have been utilized to investigate insulin sensitivity in young subjects with recent-onset ketosis-prone diabetes mellitus. All subjects presented initially with mild to moderately severe ketoacidosis and had been treated with daily insulin therapy for two to eight weeks at the time of study. Six diabetics and 10 normal subjects (group A) received intravenous infusions of glucose (6 mg./kg./min), insulin (80 mU./min.) for 150 minutes. Steady-state plasma glucose (SSPG) and insulin levels (SSPI) were reached by 90 minutes and maintained through the end of the study. As all subjects achieve simolas SSPI while simultaneously receiving similar glucose loads, the SSPG can be used to measure individual insulin sensitivity. Under these conditions the diabetics in group A had a mean SSPG (+/-S.E.) of 99+/-26 mg./100ml., which was not different from the level of 98 +/-14mg./100 ml. for their control subjects. Six diabetics and six normal subjects (group B) received infusions of only glucose (6 mg./kg./min.) and insulin (80 mU./min.). Similar SSPI levels were attained in both the diabetic and control subjects, and their mean SSPG (+/-S.E.) levels were not significantly different (83+/- 13 vs. 61 +/-6 mg./100 ml.). One diabetic in group A and two diabetics in group B had SSPG levels above the highest values measured in their control groups. However, all three had markedly elevated fasting plasma glucose levels on the day of study. In contrast, nine well-controlled diabetics had normal insulin sensitivity. These results suggest that well-controlled subjects with ketosis-prone diabetes mellitus have normal sensitivity to insulin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 403100     DOI: 10.2337/diab.26.4.278

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  Environmental factors in the development of Type 1 diabetes.

Authors:  Hui Peng; William Hagopian
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

Review 2.  Is autoimmunity or insulin resistance the primary driver of type 1 diabetes?

Authors:  Terence J Wilkin
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 3.  Metabolic acidosis-induced insulin resistance and cardiovascular risk.

Authors:  Gema Souto; Cristóbal Donapetry; Jesús Calviño; Maria M Adeva
Journal:  Metab Syndr Relat Disord       Date:  2011-02-25       Impact factor: 1.894

4.  Characterization of insulin resistance in type I diabetes.

Authors:  W Kerner; I Navascués; T von Schrenck; R Fussgänger; P Arias; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1985-06-18

5.  Insulin resistance in Type 1 (insulin-dependent) diabetes: dependence on plasma insulin concentration.

Authors:  A Pernet; E R Trimble; F Kuntschen; P Damoiseaux; J P Assal; C Hahn; A E Renold
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

Review 6.  The insulin receptor concept and its relation to the treatment of diabetes.

Authors:  G M Ward
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

7.  Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion.

Authors:  I Lager; P Lönnroth; H von Schenck; U Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

8.  Hyperglucagonemia and insulin-mediated glucose metabolism.

Authors:  S Del Prato; P Castellino; D C Simonson; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

9.  Glucose utilization in Type 1 (insulin-dependent) diabetes: Evidence for a defect not reversible by acute elevations of insulin.

Authors:  J Proietto; A Nankervis; P Aitken; G Caruso; F Alford
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

10.  Insulin resistance in alloxan-diabetic dogs: evidence for reversal following insulin therapy.

Authors:  G Caruso; J Proietto; A Calenti; F Alford
Journal:  Diabetologia       Date:  1983-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.